Clinical Trials Logo

Clinical Trial Summary

Rationale: Gastroesophageal reflux disease (GERD) is a common disease caused by a dysfunctional lower esophageal sphincter and an abnormal esophageal hiatus or hiatal hernia. Approximately 30% of large hiatal hernias will recur after surgery, in part due to weak connective tissue at the hiatus. Platelet rich plasma (PRP) is a promising autologous therapy that may address this shortcoming by substantially enhancing wound healing of the hiatus after repair. Intervention: PRP will be applied to mesh used in hiatal hernia repair. Objectives: The objective of this study is to determine the efficacy of PRP in hiatal hernia compared to traditional hernia repair without PRP. Study population: 150 patients 18 years and older with large (>5cm) paraesophageal hernias. Study methodology and study arms: a 1:1 allocation ration will be used to randomly assign 75 patients to the experimental arm (PRP with mesh) and 75 patients to the control arm (mesh only). Study outcomes: The primary outcome will be 1-year postoperative hernia recurrence based on video esophagram and/or upper endoscopy. The secondary outcome will be GERD-Health Related Quality of Life (GERD-HRQL) scores and dysphagia scores at 6 and 12 months. Follow-up: Patients who undergo fundoplication and hiatal hernia repair with mesh are seen in clinic for follow-up at two weeks, six weeks, six months, one year, and annually thereafter. Video esophagram or upper endoscopy will be performed at 1 year after surgery to assess the primary outcome. The investigators secondary outcome of reduction in GERD-HRQL score will be determined by a difference in the GERD-HRQL score from the preoperative score to the postoperative scores taken at 6 months and 1 year. The investigators secondary outcome of dysphagia will be determined by EAT-10 scores taken at 6 months and 1 year. Statistics/Analysis: Descriptive statistics will be used. Intention to treat and per protocol analyses will be performed. Frequentist and Bayesian statistical analyses will be used to determine statistically and clinically important outcomes.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05023174
Study type Interventional
Source University of Southern California
Contact
Status Enrolling by invitation
Phase N/A
Start date October 18, 2021
Completion date October 1, 2024

See also
  Status Clinical Trial Phase
Recruiting NCT05326113 - The Effect of Physiotherapy on Post POEM Reflux N/A
Recruiting NCT05303298 - Evaluating Acid Reflux After Oesophageal Stenting Using Anti-reflux Stents N/A
Recruiting NCT05750186 - The Effect of Abdominal Massage Applied After Surgery N/A
Completed NCT03659487 - Comparison of Total and Partial Fundoplication During Surgery of Patients With Gastroesophageal Reflux Disease N/A
Completed NCT05634187 - One-stop-shop Endoscopy in Reflux-patients: Evaluation of ENT and GI Features
Terminated NCT02749071 - An Investigation of the EndoStim® Lower Esophageal Sphincter (LES) Stimulation System for the Treatment of Reflux N/A
Completed NCT04651829 - Suspicion of Non IgE-mediated Cow's Milk Protein Allergy: Prevalence and Evolution
Completed NCT00551473 - Open-label Comparison of 24hr Gastric pH on Days 1, 2, 7 With Once-daily Administration of Lavoltidine 40 mg. Phase 1
Completed NCT00405119 - A Study To Investigate The Effectiveness Of AH234844 (Lavoltidine) Compared With NEXIUM And Ranitidine. Phase 2
Completed NCT03959020 - Applying Long-term Follow-up to Improve Patient Selection in Laparoscopic Anti-reflux Surgery
Not yet recruiting NCT05425771 - ARMA (Antireflux Mucosa Ablation) in Patients With Chronic Refractory Reflux Disease N/A
Recruiting NCT04695171 - LINX Reflux Management System or Fundoplication Clinical Study in Patients With Hiatal Hernia >3 cm
Completed NCT04344964 - Endoscopy-related Phone Consultation During the COVID-19 Outbreak